Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Consideration and Approval ....
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs has informed the stock exchanges that its Board of Directors will meet on Thursday, 13 November 2025 to consider and approve the unaudited financial results (both standalone and consolidated) for the half year ended 30 September 2025. This is a routine compliance filing under SEBI's Listing Regulations. The company has also confirmed that its insider trading window has been closed since 1 October 2025 and will reopen 48 hours after the financial results are publicly disclosed. No specific financial numbers, guidance, or strategic decisions have been disclosed in this intimation.
This is a standard pre-results announcement and does not by itself indicate any positive or negative development. Shareholders should watch for the actual H1FY26 results on 13 November, as the figure could trigger a short-term price reaction. The closed trading window signals that insiders are restricted from trading until results are out.